Antibody-based antiangiogenic cancer therapy

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.9, Iss.6, 2005-12, pp. : 1235-1245

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Therapy Strategies: Providing Options for the Cancer Patient

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1749-1764

Bentham Science Publishers

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy

Current Drug Targets, Vol. 12, Iss. 12, 2011-11 ,pp. : 1744-1760

Bentham Science Publishers

Access to resources Recommend Favorite